10-Q Filing

CELLDEX THERAPEUTICS, INC. CIK: 744218 Q1 2022

Filing Information

Form Type	10-Q
Accession Number	`0001104659-22-056442`
Period End Date	20220331
Filing Date	20220505
Fiscal Year	2022
Fiscal Period	Q1
XBRL Instance	cldx-20210930x10q_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 70 Income Statement 32 Cash Flow Statement 45

Balance Sheet 70 line items

Line Item	Tag	Value	Unit	Period
Convertible Preferred Stock, Par Value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Convertible Preferred Stock, Par Value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Convertible Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	3.00M	shares	Point-in-time
Convertible Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	3.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$25.29M	USD	Point-in-time
Convertible Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Convertible Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$39.14M	USD	Point-in-time
Convertible Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$369.11M	USD	Point-in-time
Convertible Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$355.18M	USD	Point-in-time
Common Stock, Par Value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Accounts and other receivables	`AccountsAndOtherReceivablesNetCurrent`	$243.00K	USD	Point-in-time
Accounts and other receivables	`AccountsAndOtherReceivablesNetCurrent`	$172.00K	USD	Point-in-time
Common Stock, Par Value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	297.00M	shares	Point-in-time
Prepaid and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$9.99M	USD	Point-in-time
Prepaid and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$2.42M	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	297.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$410.84M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$390.70M	USD	Point-in-time
Common Stock, Shares Issued	`CommonStockSharesIssued`	46.73M	shares	Point-in-time
Common Stock, Shares Issued	`CommonStockSharesIssued`	46.75M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$3.48M	USD	Point-in-time
Common Stock, Shares Outstanding	`CommonStockSharesOutstanding`	46.75M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$3.55M	USD	Point-in-time
Common Stock, Shares Outstanding	`CommonStockSharesOutstanding`	46.73M	shares	Point-in-time
Operating lease right-of-use assets, net	`OperatingLeaseRightOfUseAsset`	$2.56M	USD	Point-in-time
Operating lease right-of-use assets, net	`OperatingLeaseRightOfUseAsset`	$2.97M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$27.19M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$27.19M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$104.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$104.00K	USD	Point-in-time
Total assets	`Assets`	$424.04M	USD	Point-in-time
Total assets	`Assets`	$444.65M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.02M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.23M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$12.00M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$9.23M	USD	Point-in-time
Current portion of operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$1.80M	USD	Point-in-time
Current portion of operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$1.75M	USD	Point-in-time
Current portion of long-term liabilities	`OtherLiabilitiesCurrent`	$2.50M	USD	Point-in-time
Current portion of long-term liabilities	`OtherLiabilitiesCurrent`	$1.55M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$16.53M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$14.56M	USD	Point-in-time
Long-term portion of operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$1.30M	USD	Point-in-time
Long-term portion of operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$841.00K	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$10.54M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$7.35M	USD	Point-in-time
Total liabilities	`Liabilities`	$25.94M	USD	Point-in-time
Total liabilities	`Liabilities`	$25.18M	USD	Point-in-time
Commitments and contingent liabilities	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingent liabilities	`CommitmentsAndContingencies`	-	USD	Point-in-time
Convertible preferred stock, $.01 par value; 3,000,000 shares authorized; no shares issued and outstanding at March 31, 2022 and December 31, 2021	`PreferredStockValue`	-	USD	Point-in-time
Convertible preferred stock, $.01 par value; 3,000,000 shares authorized; no shares issued and outstanding at March 31, 2022 and December 31, 2021	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $.001 par value; 297,000,000 shares authorized; 46,754,348 and 46,730,198 shares issued and outstanding at March 31, 2022 and December 31, 2021, respectively	`CommonStockValue`	$47.00K	USD	Point-in-time
Common stock, $.001 par value; 297,000,000 shares authorized; 46,754,348 and 46,730,198 shares issued and outstanding at March 31, 2022 and December 31, 2021, respectively	`CommonStockValue`	$47.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$1.56B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$1.56B	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$112.00K	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$1.89M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.14B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.17B	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$398.10M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$209.36M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$419.48M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$194.17M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$444.65M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$424.04M	USD	Point-in-time

Income Statement 32 line items

Line Item	Tag	Value	Unit	Period
Total revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$174.00K	USD	1 Quarter
Total revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$685.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$12.72M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$17.06M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$6.91M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$4.12M	USD	1 Quarter
(Gain) loss on fair value remeasurement of contingent consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	$-483.00K	USD	1 Quarter
(Gain) loss on fair value remeasurement of contingent consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	$536.00K	USD	1 Quarter
Total operating expenses	`CostsAndExpenses`	$17.32M	USD	1 Quarter
Total operating expenses	`CostsAndExpenses`	$23.43M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-16.64M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-23.26M	USD	1 Quarter
Investment and other income, net	`InterestAndOtherIncome`	$101.00K	USD	1 Quarter
Investment and other income, net	`InterestAndOtherIncome`	$207.00K	USD	1 Quarter
Net loss	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-16.54M	USD	1 Quarter
Net loss	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-23.05M	USD	1 Quarter
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-23.05M	USD	1 Quarter
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-16.54M	USD	1 Quarter
Basic net loss per common share	`EarningsPerShareBasic`	$-0.49	USD	1 Quarter
Basic net loss per common share	`EarningsPerShareBasic`	$-0.42	USD	1 Quarter
Diluted net loss per common share	`EarningsPerShareDiluted`	$-0.42	USD	1 Quarter
Diluted net loss per common share	`EarningsPerShareDiluted`	$-0.49	USD	1 Quarter
Shares used in calculating basic net loss per share	`WeightedAverageNumberOfSharesOutstandingBasic`	46.74M	shares	1 Quarter
Shares used in calculating basic net loss per share	`WeightedAverageNumberOfSharesOutstandingBasic`	39.61M	shares	1 Quarter
Shares used in calculating diluted net loss per share	`WeightedAverageNumberOfDilutedSharesOutstanding`	46.74M	shares	1 Quarter
Shares used in calculating diluted net loss per share	`WeightedAverageNumberOfDilutedSharesOutstanding`	39.61M	shares	1 Quarter
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-23.05M	USD	1 Quarter
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-16.54M	USD	1 Quarter
Unrealized loss on marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-2.00K	USD	1 Quarter
Unrealized loss on marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-1.78M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-16.54M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-24.83M	USD	1 Quarter

Cash Flow Statement 45 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-23.05M	USD	1 Quarter
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-16.54M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$775.00K	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$811.00K	USD	1 Quarter
Amortization and premium of marketable securities, net	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$48.00K	USD	1 Quarter
Amortization and premium of marketable securities, net	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-772.00K	USD	1 Quarter
Gain on sale or disposal of assets	`GainLossOnSaleOfPropertyPlantEquipment`	$24.00K	USD	1 Quarter
(Gain) loss on fair value remeasurement of contingent consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	$-483.00K	USD	1 Quarter
(Gain) loss on fair value remeasurement of contingent consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	$536.00K	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$3.15M	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$1.27M	USD	1 Quarter
Accounts and other receivables	`IncreaseDecreaseInAccountsAndOtherReceivables`	$71.00K	USD	1 Quarter
Accounts and other receivables	`IncreaseDecreaseInAccountsAndOtherReceivables`	$26.00K	USD	1 Quarter
Prepaid and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$7.15M	USD	1 Quarter
Prepaid and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$2.14M	USD	1 Quarter
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-1.27M	USD	1 Quarter
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-2.74M	USD	1 Quarter
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$4.27M	USD	1 Quarter
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-578.00K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-24.53M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-18.08M	USD	1 Quarter
Sales and maturities of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$78.00M	USD	1 Quarter
Sales and maturities of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$27.84M	USD	1 Quarter
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$33.97M	USD	1 Quarter
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$16.89M	USD	1 Quarter
Acquisition of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$575.00K	USD	1 Quarter
Acquisition of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$567.00K	USD	1 Quarter
Proceeds from sale or disposal of assets	`ProceedsFromSaleOfProductiveAssets`	$24.00K	USD	1 Quarter
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$10.38M	USD	1 Quarter
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$43.49M	USD	1 Quarter
Proceeds from issuance of stock from employee benefit plans	`ProceedsFromStockPlans`	$74.00K	USD	1 Quarter
Proceeds from issuance of stock from employee benefit plans	`ProceedsFromStockPlans`	$304.00K	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$74.00K	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$304.00K	USD	1 Quarter
Net (decrease) increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-13.85M	USD	1 Quarter
Net (decrease) increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$25.48M	USD	1 Quarter
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$39.14M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$69.31M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$25.29M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$43.84M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$39.14M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$69.31M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$25.29M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$43.84M	USD	Point-in-time
Accrued construction in progress	`ConstructionInProgressExpendituresIncurredButNotYetPaid`	$53.00K	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.